Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Aug 23;123(4):284–287.

Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).

P G Fernandez, P K Zachariah, D G Bryant, S S Missan
PMCID: PMC1704774  PMID: 7020900

Abstract

Twenty-two white men and two white women with uncomplicated essential hypertension participated in a randomized double-blind trial comparing placebo with alpha-methyldopa (750 mg/d orally) and chlorothiazide (450 mg/d orally), alone or in combination. There were no significant differences in blood pressures as measured with the patients lying down; however, with the patients standing the systolic, diastolic and mean arterial blood pressures were significantly lower (P < 0.05) after treatment with alpha-methyldopa or the combination product. The higher the blood pressure before treatment, the greater the fall with treatment. Adverse effects were infrequent.

Full text

PDF
284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown W. J., Jr, Brown F. K., Krishan I. Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation. 1971 Apr;43(4):508–519. doi: 10.1161/01.cir.43.4.508. [DOI] [PubMed] [Google Scholar]
  2. CRANSTON W. I., JUEL-JENSEN B. E., SEMMENCE A. M., JONES R. P., FORBES J. A., MUTCH L. M. EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE. Lancet. 1963 Nov 9;2(7315):966–970. doi: 10.1016/s0140-6736(63)90671-8. [DOI] [PubMed] [Google Scholar]
  3. Clark G. M., Troop R. C. One-tablet combination drug therapy in the treatment of hypertension. J Chronic Dis. 1972 Feb;25(2):57–64. doi: 10.1016/0021-9681(72)90141-5. [DOI] [PubMed] [Google Scholar]
  4. Dahl L. K. Salt and hypertension. Am J Clin Nutr. 1972 Feb;25(2):231–244. doi: 10.1093/ajcn/25.2.231. [DOI] [PubMed] [Google Scholar]
  5. Degnbol B., Dorph S., Marner T. The effect of different diuretics on elevated blood pressure and serum potassium. Acta Med Scand. 1973 May;193(5):407–410. doi: 10.1111/j.0954-6820.1973.tb10601.x. [DOI] [PubMed] [Google Scholar]
  6. GRIEBLE H. G., JOHNSTON L. C. Treatment of arterial hypertensive disease with diuretics. I. Effects on blood pressure of bendroflumethiazide, potassium chloride, and spironolactone. Arch Intern Med. 1962 Jul;110:26–33. doi: 10.1001/archinte.1962.03620190028004. [DOI] [PubMed] [Google Scholar]
  7. Klapper M. S., Richard L. S., Smith G. H. Methyldopa-chlorothiazide--a long-term evaluation. South Med J. 1970 Jan;63(1):77–81. doi: 10.1097/00007611-197001000-00019. [DOI] [PubMed] [Google Scholar]
  8. McMahon F. G. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly. JAMA. 1975 Jan 13;231(2):155–158. [PubMed] [Google Scholar]
  9. WILSON W. R., OKUN R., TETREAULT L. METHYLDOPA AND HYDROCHLOROTHIAZIDE IN PRIMARY HYPERTENSION: CONTROLLED CLINICAL TRIAL OF DRUGS SINGLY AND IN COMBINATION. JAMA. 1963 Sep 14;185:819–825. doi: 10.1001/jama.1963.03060110023012. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES